The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn’s & Colitis Foundation. Park, K. T. et al. Inflammatory Bowel Diseases, volume 26, issue 1, May 2019.
Inflammatory bowel diseases (IBD) represent an increasing disorder among children and adults worldwide. Both of their categories, Crohn’s disease and ulcerative colitis, present a chronic clinical condition that usually requires long-term care services, from hospitalizations to specific therapeutics. There is an urge to establish efficient strategies that ensure appropriate attention to the patient while maintaining financial sustainability for healthcare systems. For this purpose, identifying the main drivers of these costs could lead to implementing suitable solutions on an impactful scale.
In this article, the Crohn’s & Colitis Foundation’s Cost of Inflammatory Bowel Disease Care Initiative shows the results of a study analysing key factors involved in the annual direct and indirect healthcare costs involving patients living with IBD and the costs of newly diagnosed patients. The article also highlights requirements and strategies that may help to provide solutions to this situation.